SEC Form 4 · accession 0000899243-16-013156
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry C Johnson
Director
Period of report
Feb 9, 2016
Accepted (ET)
Feb 11, 2016 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2016 | M | 9,054 | $17.185 | A | 12,614 | D | |
| Common StockF2 | Feb 9, 2016 | S | 9,054 | $68.8964 | D | 3,560 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right-to-buy)F4,F3 | $17.185 | Feb 9, 2016 | M | 9,054 | D | — | Feb 13, 2016 | Common Stock | 9,054 | 0 | D |
Explanation of responses
- F1The number of securities reported reflects a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split").
- F2The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $68.90 to $68.93 inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,527 shares on February 14, 2010, without giving effect to the 2-for-1 "Stock Split". The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F4Not applicable.